Centromere protein H (CENP-H) is an important component of a functional centromere. Studies have demonstrated that CENP-H is overexpressed in renal cell, gastric, hypopharyngeal squamous cell, nasopharyngeal, endometrial, lung, cervical, esophageal, liver, colorectal, oral squamous cell, breast, and tongue carcinomas. CENP-H overexpression is positively correlated with a poor prognosis, pathological stage, T stage, and lymph node metastasis in patients with the above carcinomas. CENP-H can promote cancer growth and metastasis through PI3K/AKT, survivin, and mitochondrial apoptosis signaling mechanisms, and it can be regulated by long non-coding ribonucleic acid (lncRNA) plasmacytoma variant translocation 1 (PVT1)/miR-612, Sp1, or Sp3. This review aims to summarize the expression of CENP-H, the relationship between CENP-H expression and prognostic features, growth and metastasis of cancer in patients, as well as the mechanism of CENP-H in cancer. It also proposes a new candidate molecule for treating patients with cancer.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11893413 | PMC |
| http://dx.doi.org/10.3389/fonc.2025.1521988 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
CENP-H as a new prognostic biomarker for tumors: a real-world literature review.
Front Oncol
February 2025
Department of Thoracic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Centromere protein H (CENP-H) is an important component of a functional centromere. Studies have demonstrated that CENP-H is overexpressed in renal cell, gastric, hypopharyngeal squamous cell, nasopharyngeal, endometrial, lung, cervical, esophageal, liver, colorectal, oral squamous cell, breast, and tongue carcinomas. CENP-H overexpression is positively correlated with a poor prognosis, pathological stage, T stage, and lymph node metastasis in patients with the above carcinomas.
View Article and Find Full Text PDFCENP-I directly targets centromeric DNA to support CENP-A deposition and centromere maintenance.
Proc Natl Acad Sci U S A
March 2023
Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China.
The enrichment of histone H3 variant CENP-A is the epigenetic mark of centromere and initiates the assembly of the kinetochore at centromere. The kinetochore is a multi-subunit complex that ensures accurate attachment of microtubule centromere and faithful segregation of sister chromatids during mitosis. As a subunit of kinetochore, CENP-I localization at centromere also depends on CENP-A.
View Article and Find Full Text PDFMobility of kinetochore proteins measured by FRAP analysis in living cells.
Chromosome Res
March 2022
Graduate School of Frontier Biosciences, Osaka University, Osaka, Suita, 565-0871, Japan.
Article Synopsis
- The kinetochore is crucial for proper chromosome separation in mitosis and is built through complex interactions among various proteins.
- Researchers used fluorescence recovery after photobleaching (FRAP) in chicken DT40 cells to study the movement and assembly of kinetochore proteins, finding that CENP-C was mobile in interphase but not during mitosis.
- Mutations in CENP-C affected its mobility, while other proteins like CENP-T and CENP-H remained immobile throughout both stages, indicating the dynamic nature of kinetochore assembly.
Loss of CENP-I Impairs Homologous Recombination and Sensitizes Cells to PARP1 Inhibition.
Cancers (Basel)
June 2021
Stephenson Cancer Center, Department of Neurosurgery, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA.
Centromere Protein I (CENP-I) is a member of the CENP-H/I/K complex. CENP-H/I/K is a major component of the inner kinetochore and aids in ensuring proper chromosomal segregation during mitosis. In addition to this chromosomal segregation function, CENP-I also plays a role in DNA double-strand break (DSB) repair.
View Article and Find Full Text PDFThe PVT1/miR-612/CENP-H/CDK1 axis promotes malignant progression of advanced endometrial cancer.
Am J Cancer Res
April 2021
Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University Sanhao Street, Shenyang, People's Republic of China.
Our previous study introduced the oncogenic role of the long non-coding RNA plasmacytoma variant translocation 1 (PVT1) in endometrial cancer (EC). In this study, we aimed to construct a PVT1-centered competing endogenous RNA (ceRNA) network to outline a regulatory axis that might promote the malignant progression of advanced EC. Raw Uterine Corpus Endometrial Carcinoma (UCEC) datasets were collected from The Cancer Genome Atlas (TCGA) database and used for construction of the PVT1-centered ceRNA network.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!